Skip to main content

Table 2 Characteristics of patients with persistent disease according to the tumor burden

From: Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome

  Very small-volume PD (n = 24) Small-volume PD (n = 25) Large-volume PD (n = 58) p
Postoperative ATA risk     <.0001
 LR 13 (54%) 5 (20%) 4 (7%)  
 IR 11 (46%) 18 (72%) 37 (64%)  
 HR 0 2 (8%) 17 (29%)  
Preparation modality     0.007
 THW 9 (37%) 14 (56%) 42 (72%)  
 rhTSH 15 (63%) 11 (44%) 16 (28%)  
PD site     0.002
 LN 9 (38%) 17 (68%) 30 (52%)  
 LN + DM 2 (8%) 2 (8%) 8 (14%)  
 DM 13 (54%) 6 (24%) 9 (15%)  
 TB disease 0 0 6 (10%)  
 TB disease + DM 0 0 5 (9%)  
RAI and 18FDG status     <.0001
 RAI+/18FDG- or NP 22a (92%) 17b (68%) 16c (27%)  
 RAI+/18FDG+ 0 2 (8%) 12 (21%)  
 RAI−/18FDG+ 2 (8%) 6 (24%) 23 (40%)  
 RAI−/18FDG- 0 0 6 (10%)  
 RAI−/18FDG NP 0 0 1 (2%)  
  1. a21 RAI+/18FDG NP and one RAI+/18FDG-
  2. b15 RAI+/18FDG NP and two RAI+/18FDG-
  3. c10 RAI+/18FDG NP and six RAI+/18FDG-